Literature DB >> 3421940

Interactions of inhibitors of carnitine palmitoyltransferase I and fibrates in cultured hepatocytes.

P Gerondaes1, K G Alberti, L Agius.   

Abstract

Culture of rat hepatocytes with etomoxir, an inhibitor of carnitine palmitoyltransferase I (CPT I), for 48 h, resulted in increased carnitine acetyltransferase (CAT) activity (74%), a marked decrease in CPT activity (82%) measured in detergent extracts, and increased activities of glucose-6-phosphate dehydrogenase (227%) and fructose-1,6-bisphosphatase (65%). Changes in CAT and CPT activities were not observed after 4 h culture with etomoxir. When hepatocytes were cultured with etomoxir and benzafibrate (a hypolipidaemic analogue of clofibrate) for 48 h, etomoxir prevented the 5-fold increase in CAT activity caused by bezafibrate, whereas bezafibrate suppressed the increase in glucose-6-phosphate dehydrogenase and fructose-bisphosphatase caused by etomoxir. However, bezafibrate did not prevent the suppression of CPT activity by etomoxir. Etomoxir inhibited palmitate beta-oxidation and ketogenesis after short-term (0-4 h) and long-term (48 h) exposure, but it caused accumulation of triacylglycerol in hepatocytes only after short-term exposure (0-4 h). These effects of etomoxir on fatty acid metabolism and suppression of CPT (after 48 h) were similar in periportal and perivenous hepatocytes, but the increases in CAT and glucose-6-phosphate dehydrogenase activities were higher in periportal than in perivenous cells. The effects of CPT I inhibitors on CAT activity and long-term suppression of CPT activity are probably mediated by independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421940      PMCID: PMC1149271          DOI: 10.1042/bj2530169

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

Review 1.  Preparation of isolated rat liver cells.

Authors:  P O Seglen
Journal:  Methods Cell Biol       Date:  1976       Impact factor: 1.441

2.  The activity of the different carnitine acyltransferases in the liver of clofibrate-fed rats.

Authors:  H E Solberg; M Aas; L N Daae
Journal:  Biochim Biophys Acta       Date:  1972-11-30

3.  Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors.

Authors:  P E Declercq; J R Falck; M Kuwajima; H Tyminski; D W Foster; J D McGarry
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

4.  Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. II. Use of detergents and antibodies.

Authors:  K F Woeltje; M Kuwajima; D W Foster; J D McGarry
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

5.  Inhibition of metabolic processes by coenzyme-A-sequestering aromatic acids. Prevention by para-chloro- and para-nitrobenzoic acids.

Authors:  M S Swartzentruber; R A Harris
Journal:  Biochem Pharmacol       Date:  1987-10-01       Impact factor: 5.858

6.  Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat.

Authors:  R Hess; W Stäubli; W Riess
Journal:  Nature       Date:  1965-11-27       Impact factor: 49.962

7.  Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.

Authors:  J K Reddy; T P Krishnakantha
Journal:  Science       Date:  1975-11-21       Impact factor: 47.728

8.  Prevention of peroxisomal proliferation by carnitine palmitoyltransferase inhibitors in cultured rat hepatocytes and in vivo.

Authors:  R Hertz; J Bar-Tana
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

9.  A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

Authors:  P B Lazarow; C De Duve
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

10.  Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB).

Authors:  D J Svoboda; D L Azarnoff
Journal:  J Cell Biol       Date:  1966-08       Impact factor: 10.539

View more
  5 in total

1.  Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes.

Authors:  Rouhallah Najjar Sadeghi; Fatemeh Karami-Tehrani; Siamak Salami
Journal:  Tumour Biol       Date:  2014-12-12

2.  Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.

Authors:  Tyler G Demarest; Vijay R Varma; Darlene Estrada; Mansi Babbar; Sambuddha Basu; Uma V Mahajan; Ruin Moaddel; Deborah L Croteau; Madhav Thambisetty; Mark P Mattson; Vilhelm A Bohr
Journal:  Acta Neuropathol       Date:  2020-04-24       Impact factor: 17.088

3.  Linoleic acid stimulates [Ca2+]i increase in rat pancreatic beta-cells through both membrane receptor- and intracellular metabolite-mediated pathways.

Authors:  Yufeng Zhao; Li Wang; Jianhua Qiu; Dingjun Zha; Qiang Sun; Chen Chen
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

4.  In vitro screening for compounds that enhance human L1 mobilization.

Authors:  Natsuko Terasaki; John L Goodier; Ling E Cheung; Yue J Wang; Masaki Kajikawa; Haig H Kazazian; Norihiro Okada
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

5.  Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism.

Authors:  Elisabeth Altmaier; Gisela Fobo; Margit Heier; Barbara Thorand; Christine Meisinger; Werner Römisch-Margl; Melanie Waldenberger; Christian Gieger; Thomas Illig; Jerzy Adamski; Karsten Suhre; Gabi Kastenmüller
Journal:  Eur J Epidemiol       Date:  2014-05-10       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.